Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2026-05-27 Major Shareholding Noti…
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Change in substantial holding 3 pages 938.4KB
Major Shareholding Notification Classification · 98% confidence The document is an Australian Form 604 Notice under Section 671B of the Corporations Act 2001 detailing changes in relevant interests of a substantial shareholder in Osteopore Limited, including previous and present voting power and particulars of trades. This is clearly a Major Shareholding Notification rather than a financial report or other corporate announcement.
2026-05-27 English
OSX secures Hainan FDA approval for orthopaedic devices 5 pages 464.4KB
Regulatory Filings Classification · 93% confidence The document is an ASX announcement by Osteopore Limited announcing regulatory approval from the Hainan Medical Products Administration for its custom orthopaedic devices. It is a corporate news release regarding a clinical license approval rather than financial results, management discussion, capital changes, or a specific meeting proxy. It does not contain financial statements or executive certifications. Therefore, it is best classified as a general regulatory announcement, which falls under the Regulatory Filings (RNS) category.
2026-05-25 English
Results of Annual General Meeting 2 pages 348.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement dated 21 May 2026 detailing the results of the Annual General Meeting, including proxy votes and poll outcomes for each resolution. It discloses voting results in accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act. This matches a Declaration of Voting Results & Voting Rights Announcement.
2026-05-20 English
OSX orthopaedic products gain Malaysian market access rights 4 pages 463.4KB
Regulatory Filings Classification · 85% confidence The document is an ASX announcement describing Osteopore’s receipt of regulatory access to the Malaysian market. It is a corporate/regulatory update press release, not a full financial report, capital raise, management change, or meeting-related material. It does not contain financial statements or voting outcomes. It best fits the general regulatory announcement category as a Regulatory Filing (RNS).
2026-05-14 English
Application for quotation of securities - OSX 7 pages 20.1KB
Share Issue/Capital Change Classification · 85% confidence The document is an ASX Appendix 2A “Application for quotation of securities,” detailing an employee incentive share issue and the request to list these new securities on the exchange. This is an announcement of new share issuance/capital change rather than a financial report or earnings release. Thus, it falls under Share Issue/Capital Change (SHA).
2026-05-11 English
Cleansing Notice 1
Regulatory Filings Classification · 85% confidence The document is an ASX “Cleansing Notice” under section 708A of the Corporations Act, providing regulatory compliance statements in relation to securities issued via Appendix 2A. It does not contain financial results, management commentary, or a substantive report, but rather a regulatory compliance announcement. This falls under the general “Regulatory Filings” (RNS) category as a fallback for miscellaneous compliance announcements.
2026-05-11 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.